Small molecule KSM/RSM/APIs. Specialties; large-scale hydrogenation, chiral, sulfur, and transition metal-containing compounds
Developing novel mRNA-based cancer therapies targeting solid tumors with high unmet need.
Precision medicine approach for autoimmune disorders using proprietary antibody-drug conjugate technology.
Targeting neurological disorders through blood-brain barrier penetrant small molecules.
Upgrade to access detailed therapeutic area information for this company and unlock all premium features.
